Differences in gene expression profiles from asbestos-treated SPARC-null and wild-type mouse lungs

Genomics

Volumn 94, Issue 2, 2009, Pages 101-109

  Pershouse, Mark A ^a   Smartt, Aubrey M ^a   Schwanke, Corbin ^a   Putnam, Elizabeth A ^a  

^a UNIVERSITY OF MONTANA   (United States)

Author keywords

Amphibole; Asbestos; Fibrosis; Hevin; Knockout mice; Microarray analysis; Osteonectin; SPARC

Indexed keywords

CROCIDOLITE; FRIZZLED PROTEIN; MEMBRANE PROTEIN; OSTEONECTIN; RNA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASBESTOSIS; BONE GROWTH; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FIBROBLAST; GENE CONTROL; GENE EXPRESSION PROFILING; GENE FUNCTION; LUNG FIBROSIS; MALE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; NULL ALLELE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN TRANSPORT; SIGNAL TRANSDUCTION; UNINDEXED SEQUENCE; WILD TYPE;

ANIMALS; ASBESTOS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; OSTEONECTIN; TRANSCRIPTION, GENETIC; UP-REGULATION;

ANIMALIA; MUS;

EID: 67649976601     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2009.04.009     Document Type: Article

References (27)

1. Kuhn C., and Mason R.J. Immunolocalization of SPARC, tenascin, and thrombospondin in pulmonary fibrosis. Am. J. Path. 147 (1995) 1759-1769
2. Hunzelmann N., Hafner M., Anders S., Krieg T., and Nischt R. BM-40 (osteonectin, SPARC) is expressed both in the epidermal and in the dermal compartment of adult human skin, J. Invest. Dermatol. 110 (1998) 122-126
3. Bradshaw A.D., and Sage E.H. SPARC, a matricellular protein that functions in cellular differentiation and tissue response to injury. J. Clin. Invest. 107 (2001) 1049-1054
4. Wang H., et al. Secreted protein acidic and rich in cysteine (SPARC/osteonectin/BM-40) binds to fibrinogen fragments D and E, but not to native fibrinogen. Matrix Biol. 5 (2006) 20-26
5. Schiemann B.J., Neil J.R., and Schiemann W.P. SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-β-signaling system. Mol. Biol. Cell. 14 (2003) 3977-3988
6. Framson P.E., and Sage E.H. SPARC and tumor growth: where the seed meets the soil?. J. Cell. Biochem. 92 (2004) 679-690
7. Siddiq F., Sarkar F.H., Wali A., Pass H.I., and Lonardo F. Increased osteonectin expression is associated with malignant transformation and tumor associated fibrosis in the lung. Lung Cancer 45 (2004) 197-205
8. Barker T.H., et al. SPARC regulates extracellular matrix organization through its modulation of integrin-linked kinase activity. J. Biol. Chem. 280 (2005) 36483-36493
9. Sage E.H., et al. Cleavage of the matricellular protein SPARC by matrix metalloproteinase 3 produces polypeptides that influence angiogenesis. J. Biol. Chem. 278 (2003) 37849-37857
10. Francki A., et al. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells. J. Cell. Biochem. 91 (2004) 915-925
11. Kzhyshkowska J., et al. Novel function of alternatively activated macrophages: stabilin-1-mediated clearance of SPARC. J. Immun. 176 (2006) 5825-5832
12. Brekken R.A., and Sage E.H. SPARC, a matricellular protein: at the crossroads of cell-matrix communication. Matrix Biol. 19 (2000) 816-827
13. Sullivan M.M., and Sage E.H. Hevin/SC1, a matricellular glycoprotein and potential tumor-suppressor of the SPARC/BM-40/Osteonectin family. Int. J. Biochem. Cell Biol. 36 (2004) 991-996
14. Gilmour D.T., et al. Mice deficient for the secreted glycoprotein SPARC/osteonectin/BM40 develop normally but show severe age-onset cataract formation and disruption of the lens. EMBO J. 17 (1998) 1860-1870
15. Norose K., et al. SPARC deficiency leads to early-onset cataractogenesis. Invest. Ophthalmol. Vis. Sci. 39 (1998) 2674-2680
16. Smartt A.M., Brezinski M., Trapkus M., Gardner D., and Putnam E.A. Collagen accumulation over time in the murine lung after exposure to crocidolite asbestos or Libby amphibole. Env. Toxicol. (2009) Feb 13 [epub ahead of print], doi:10.1002/tox.20472
17. Strandjord T.P., Madtes D.K., Weiss D.J., and Sage E.H. Collagen accumulation is decreased in Sparc-null mice with bleomycin-induced pulmonary fibrosis. Am. J. Physiol. 277 (1999) L628-L635
18. Uematsu K., et al. Targeting the Wnt signaling pathway with dishevelled and cisplatin synergistically suppresses mesothelioma cell growth. Anticancer Res. 27 (2007) 4239-4242
19. Mathew L.K., Simonich M.T., and Tanguay R.L. AHR-dependent misregulation of Wnt signaling disrupts tissue regeneration. Biochem. Pharmacol. 77 (2008) 498-507
20. Shackel N.A., McGuinness P.H., Abbott C.A., Gorrell M.D., and McCaughan G.W. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am. J. Pathol. 160 (2002) 641-654
21. Chatterjee B., et al. BMP regulation of the mouse connexin43 promoter in osteoblastic cells and embryos. Cell Commun. Adhes. 10 (2003) 37-50
22. Kim J.K., et al. Expression and localization of surfactant proteins in human nasal epithelium. Am. J. Physiol. Lung Cell Mol. Physiol. 292 (2007) L879-L884
23. Leung K.H., Pippalla V., Kreutter A., and Chandler M. Functional effects of FGF-13 on human lung fibroblasts, dermal microvascular endothelial cells, and aortic smooth muscle cells. Biochem. Biophys. Res. Commun. 250 (1998) 137-142 Erratum in: Biochem. Biophys. Res. Commun. 251 (1998) 667
24. Jaradat M., et al. Modulatory role for retinoid-related orphan receptor alpha in allergen-induced lung inflammation. Am. J. Respir. Crit. Care Med. 174 (2006) 1299-1309
25. Wilhelm M.T., Mendez-Vidal C., and Wiman K.G. Identification of functional p53-binding motifs in the mouse wig-1 promoter. FEBS Lett. 524 (2002) 69-72
26. Katoh M. WNT signaling in stem cell biology and regenerative medicine. Curr. Drug Targets 9 (2008) 565-570
27. Adamson I.Y., and Bowden D.H. Response of mouse lung to crocidolite asbestos. 2. Pulmonary fibrosis after long fibres, J. Pathol. 152 (1987) 109-117